Discover if this is a suitable investor for your startup. If they are we'll make a warm introduction for free. Otherwise, we'll connect you with matching investors.
Jumpspace Ventures is a New York-based early-stage venture-capital firm founded in 2024. The firm specializes in neurotechnology devices, aiming to enhance human-machine interfaces and improve healthcare outcomes through advanced neurotechnological solutions. Jumpspace Ventures positions itself as a dedicated investor in the neurotech space, focusing on innovations that drive advancements in neural interfaces and bioelectronic medicine.
Currently, Jumpspace Ventures operates with a commitment to supporting groundbreaking developments in neurotechnology. The firm emphasizes technical depth, clinical relevance, and regulatory awareness, which are critical for navigating the complexities of bringing advanced neurotechnological solutions to market. Although specific details regarding assets under management (AUM) and fund size are not disclosed, the firm is actively seeking to partner with startups that align with its investment thesis.
Jumpspace Ventures invests in early-stage companies that focus on neurotechnology and healthcare-related deep tech. The firm specifically targets innovations in neural interfaces, brain-computer interfaces, and bioelectronic medicine. Jumpspace Ventures aims to transform the way humans interact with technology and improve healthcare delivery through its investments.
The firm is particularly interested in supporting startups that are developing groundbreaking solutions in neurotechnology. Jumpspace Ventures seeks to partner with founders who demonstrate technical depth and a clear understanding of clinical relevance and regulatory challenges. This focus on early-stage investments spans pre-seed, seed, and Series A rounds, primarily within the United States.
Jumpspace Ventures has invested in several notable companies within the neurotechnology sector:
These companies exemplify Jumpspace Ventures' commitment to supporting innovations that enhance human-machine interactions and improve healthcare outcomes.
Adam Caplan: Founder and General Partner at Jumpspace Ventures. Adam has a background in venture capital and specializes in neurotechnology investments. His expertise includes identifying promising startups in the neurotech space and guiding them through the early stages of development.
Sam Hosovsky: Listed as an employee on the Jumpspace Ventures LinkedIn page. Specific roles and contributions have not been detailed, but he is part of the team supporting the firm's investment activities.
To pitch Jumpspace Ventures, founders should use the email address info@jumpspace.vc. It is recommended to include a comprehensive pitch deck that outlines the startup's technology, market potential, and alignment with Jumpspace's focus on neurotechnology. Founders should expect a response time that varies based on the firm's current engagement levels.
Warm introductions can enhance the chances of a successful pitch, so leveraging any connections within the neurotechnology or healthcare sectors may be beneficial.
As of April 2026, Jumpspace Ventures has been actively investing in the neurotechnology sector. The firm participated in a seed round for Sharper Sense in 2025, indicating ongoing engagement with emerging companies in the field. Additionally, Jumpspace Ventures continues to support its portfolio companies, including Phantom Neuro and NeuroBionics, which are making strides in human-machine interfacing and neural interface technology.
What are Jumpspace Ventures' investment criteria?
Jumpspace Ventures focuses on early-stage companies in the neurotechnology and healthcare sectors. They look for innovations in neural interfaces, brain-computer interfaces, and bioelectronic medicine. The firm values technical depth, clinical relevance, and regulatory awareness in potential investments.
How can I pitch to Jumpspace Ventures?
Founders can pitch Jumpspace Ventures by reaching out via their email at info@jumpspace.vc. It is advisable to include a detailed overview of the startup, the technology being developed, and how it aligns with Jumpspace's focus on neurotechnology.
What makes Jumpspace Ventures different from other VCs?
Jumpspace Ventures specializes exclusively in neurotechnology devices, setting it apart from generalist venture capital firms. Their deep expertise in this niche allows them to provide tailored support to portfolio companies.
What is the geographic focus of Jumpspace Ventures?
The firm primarily invests in companies based in the United States, with a specific emphasis on those located in New York.
What is the typical check size for investments?
While specific check sizes are not disclosed, Jumpspace Ventures invests in early-stage rounds, which typically range from pre-seed to Series A funding.
What kind of post-investment support does Jumpspace Ventures provide?
Jumpspace Ventures offers strategic support to its portfolio companies, leveraging its expertise in neurotechnology and healthcare to help founders navigate market complexities.
All trademarks, logos and brand names are the property of their respective owners. All company, product and service names used in this website are for identification purposes only. Use of these names, trademarks, and brands does not imply endorsement.